$LH LABORATORY CORP OF AMERICA HOLDINGS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LABORATORY CORP OF AMERICA HOLDINGS. Insider overview, share value development, latest insider transactions and email notifications about new events in LABORATORY CORP OF AMERICA HOLDINGS for free.
IRS Number: 133757370
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Trading Symbol: LH
Company Address: 358 S MAIN ST BURLINGTON 27215
Former name: NATIONAL HEALTH LABORATORIES HOLDINGS INC, date of change: 1994-03-14
Market Capitalization: $13.45B
Prev close: $129.86
Average Daily Volume: 776,769
Days Low: $129.42
Year Low: $100.98
Year High: $141.32
LABORATORY CORP OF AMERICA HOLDINGS Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Sell | S | 276.55 | 2,500 | 691,375 | 7,844 | 10.3 K to 7.8 K (-24.17 %) |
| May 05 2021 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 98.49 | 2,600 | 256,074 | 0 | |
| May 05 2021 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Sell | S | 269.16 | 2,600 | 699,803 | 15,569 | 18.2 K to 15.6 K (-14.31 %) |
| May 05 2021 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 98.49 | 2,600 | 256,074 | 18,169 | 15.6 K to 18.2 K (+16.70 %) |
| Apr 06 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 1,010 | 0 | 6,781 | |
| Apr 06 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Payment of Exercise | F | 252.67 | 452 | 114,207 | 10,344 | 10.8 K to 10.3 K (-4.19 %) |
| Apr 06 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Buy | M | 0.00 | 1,010 | 0 | 10,796 | 9.8 K to 10.8 K (+10.32 %) |
| Apr 01 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Sell | S | 251.88 | 667 | 168,004 | 5,006 | 5.7 K to 5 K (-11.76 %) |
| Apr 01 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Sell | S | 251.88 | 812 | 204,527 | 5,237 | 6 K to 5.2 K (-13.42 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 251.58 | 3,595 | 904,430 | 37,433 | 41 K to 37.4 K (-8.76 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Grant | A | 0.00 | 8,042 | 0 | 41,028 | 33 K to 41 K (+24.38 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Payment of Exercise | F | 251.58 | 1,079 | 271,455 | 14,186 | 15.3 K to 14.2 K (-7.07 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Grant | A | 0.00 | 2,413 | 0 | 15,265 | 12.9 K to 15.3 K (+18.78 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | Caveney Brian J | EVP, President of D ... | Payment of Exercise | F | 251.58 | 1,079 | 271,455 | 8,001 | 9.1 K to 8 K (-11.88 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | Caveney Brian J | EVP, President of D ... | Grant | A | 0.00 | 2,413 | 0 | 9,080 | 6.7 K to 9.1 K (+36.19 %) |
View all LABORATORY CORP OF AMERICA HOLDINGS insider transactions.